From too much hunger to pimples: 5 common signs of worms that adults often ignore

Worm infections are generally thought of as a childhood problem. The truth, however, is that adults too carry a risk, ...

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

Achieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged “8 years and older”Expanded age ...
MedPage Today on MSN

Migraine Drug Shows Promise as IBS Treatment in Small Trial

A migraine medication targeting calcitonin gene-related peptide (CGRP) pathways wasn't shown to improve daily abdominal pain scores in irritable bowel syndrome (IBS), but it may help reduce gut pain ...
Yahoo Finance

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

CARMEL, Ind., Oct. 24, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Conference call will be held today, Tuesday, November 11 at 9:00 am ETCARMEL, Ind., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical ...
Medical Dialogues

FDA Approves Linaclotide as First Treatment for IBS-C in Children Aged 7 and Older

The FDA has approved linaclotide (Linzess) capsules for treating irritable bowel syndrome with constipation (IBS-C) in ...
Medical Dialogues

Small Intestinal Dilation Linked to Severe Symptoms in Adult patients with FPIES: Study

According to a new study published in the journal of Allergy, small intestinal dilation contributes to severe abdominal ...
The Pharma Letter

FDA clears first IBS-C treatment for children

The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...
PharmiWeb

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

KYGEVVI® (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom ...

Early-onset of colon cancer is rising in young adults: 5 things to know

When you think of colorectal cancer — more commonly known as colon cancer — you likely imagine someone over 50. But ...
Health.com

What To Expect With Stomach Cancer Treatment

The treatment goals and options for stomach cancer vary depending on how advanced the cancer is and how far it has spread. Surgery is often an effective treatment option for people with early-stage ...
Investing

Neuraxis stock rises after FDA clearance for abdominal pain treatment

Investing.com -- Neuraxis Inc (NASDAQ:NRIX) stock gained 4.2% in premarket trading Friday after the company received FDA clearance for its nerve stimulation technology to treat functional abdominal ...